Clinical practice guidance for next‐generation sequencing in cancer diagnosis and treatment (Edition 1.0)
-
- Kuniko Sunami
- Department of Pathology and Clinical Laboratories National Cancer Center Hospital Tokyo Japan
-
- Hideaki Takahashi
- Department of Hepatobiliary and Pancreatic Oncology National Cancer Center Hospital East Kashiwa Japan
-
- Katsuya Tsuchihara
- Division of Translational Informatics Exploratory Oncology Research and Clinical Trial Center National Cancer Center Kashiwa Japan
-
- Masayuki Takeda
- Department of Medical Oncology Kindai University Faculty of Medicine Osaka Japan
-
- Tatsuya Suzuki
- Department of Hematology National Cancer Center Hospital Tokyo Japan
-
- Yoichi Naito
- Department of Breast and Medical Oncology National Cancer Center Hospital East Kashiwa Japan
-
- Kazuko Sakai
- Department of Genome Biology Kindai University Faculty of Medicine Osaka Japan
-
- Hirotoshi Dosaka‐Akita
- Department of Medical Oncology Hokkaido University Graduate School of Medicine Hokkaido Japan
-
- Chikashi Ishioka
- Department of Medical Oncology Tohoku University Hospital Miyagi Japan
-
- Yasuhiro Kodera
- Department of Gastroenterological Surgery Nagoya University Graduate School of Medicine Aichi Japan
-
- Manabu Muto
- Department of Therapeutic Oncology Graduate School of Medicine Kyoto University Kyoto Japan
-
- Toshifumi Wakai
- Division of Digestive and General Surgery Niigata University Graduate School of Medical and Dental Sciences Niigata Japan
-
- Kentaro Yamazaki
- Division of Gastrointestinal Oncology Shizuoka Cancer Center Shizuoka Japan
-
- Wataru Yasui
- Department of Molecular Pathology Hiroshima University Hiroshima Japan
-
- Hideaki Bando
- Department of Gastrointestinal Oncology National Cancer Center Hospital East Kashiwa Japan
-
- Yumi Fujimoto
- Department of Breast and Medical Oncology National Cancer Center Hospital East Kashiwa Japan
-
- Shota Fukuoka
- Department of Gastrointestinal Oncology National Cancer Center Hospital East Kashiwa Japan
-
- Kenichi Harano
- Department of Breast and Medical Oncology National Cancer Center Hospital East Kashiwa Japan
-
- Akihito Kawazoe
- Department of Gastrointestinal Oncology National Cancer Center Hospital East Kashiwa Japan
-
- Gen Kimura
- Department of Hepatobiliary and Pancreatic Oncology National Cancer Center Hospital East Kashiwa Japan
-
- Shigehiro Koganemaru
- Department of Experimental Therapeutics National Cancer Center Hospital East Kashiwa Japan
-
- Takahiro Kogawa
- Department of Breast and Medical Oncology National Cancer Center Hospital East Kashiwa Japan
-
- Daisuke Kotani
- Department of Gastrointestinal Oncology National Cancer Center Hospital East Kashiwa Japan
-
- Yasutoshi Kuboki
- Department of Experimental Therapeutics National Cancer Center Hospital East Kashiwa Japan
-
- Hiroshi Matsumoto
- Department of Gastrointestinal Oncology National Cancer Center Hospital East Kashiwa Japan
-
- Shingo Matsumoto
- Department of Thoracic Oncology National Cancer Center Hospital East Kashiwa Japan
-
- Saori Mishima
- Department of Gastrointestinal Oncology National Cancer Center Hospital East Kashiwa Japan
-
- Yoshiaki Nakamura
- Department of Gastrointestinal Oncology National Cancer Center Hospital East Kashiwa Japan
-
- Kentaro Sawada
- Department of Gastrointestinal Oncology National Cancer Center Hospital East Kashiwa Japan
-
- Sumito Shingaki
- Department of Experimental Therapeutics National Cancer Center Hospital East Kashiwa Japan
-
- Kohei Shitara
- Department of Gastrointestinal Oncology National Cancer Center Hospital East Kashiwa Japan
-
- Kumiko Umemoto
- Department of Hepatobiliary and Pancreatic Oncology National Cancer Center Hospital East Kashiwa Japan
-
- Shigeki Umemura
- Department of Thoracic Oncology National Cancer Center Hospital East Kashiwa Japan
-
- Kayo Yasuda
- Department of Gastrointestinal Oncology National Cancer Center Hospital East Kashiwa Japan
-
- Takayuki Yoshino
- Department of Gastrointestinal Oncology National Cancer Center Hospital East Kashiwa Japan
-
- Noboru Yamamoto
- Department of Experimental Therapeutics National Cancer Center Hospital Tokyo Japan
-
- Kazuto Nishio
- Department of Genome Biology Kindai University Faculty of Medicine Osaka Japan
この論文をさがす
抄録
<jats:p>In Japan, the social (medical) health‐care system is on the way to being developed to advance personalized medicine through the implementation of cancer genomic medicine, known as “cancer clinical sequencing,” which uses a next‐generation sequencer. However, no Japanese guidance for cancer genomic testing exists. Gene panel testing can be carried out to help determine patient treatment, confirm diagnosis, and evaluate prognostic predictions of patients with mainly solid cancers for whom no standard treatment is available. This guidance describes how to utilize gene panel testing according to the type of cancer: childhood cancer, rare cancer, carcinoma of unknown primary, and other cancers. The level of evidence classification for unified use in Japan is also detailed. This guidance establishes the basic principles of the quality control of specimens, requirements of medical institutions, informed consent, handling of data during the postanalysis stage, and treatment options based on the evidence level. In Japan, gene panel testing for cancer treatment and diagnosis is recommended to comply with this guidance. This is a collaborative work of the Japanese Society of Medical Oncology, Japan Society of Clinical Oncology, and the Japanese Cancer Association.</jats:p>
収録刊行物
-
- Cancer Science
-
Cancer Science 109 (9), 2980-2985, 2018-09
Wiley
- Tweet
詳細情報
-
- CRID
- 1360004235490267392
-
- ISSN
- 13497006
- 13479032
-
- データソース種別
-
- Crossref
- KAKEN